Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Confluent (CFLT) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Confluent (CFLT) over the last 6 years, with Q3 2025 value amounting to $5.4 million.

  • Confluent's Capital Expenditures fell 458.63% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.8 million, marking a year-over-year increase of 760.74%. This contributed to the annual value of $21.4 million for FY2024, which is 1994.4% up from last year.
  • Per Confluent's latest filing, its Capital Expenditures stood at $5.4 million for Q3 2025, which was down 458.63% from $6.2 million recorded in Q2 2025.
  • Confluent's Capital Expenditures' 5-year high stood at $6.2 million during Q2 2025, with a 5-year trough of $643000.0 in Q1 2021.
  • Its 5-year average for Capital Expenditures is $3.8 million, with a median of $4.3 million in 2023.
  • As far as peak fluctuations go, Confluent's Capital Expenditures soared by 29020.22% in 2022, and later crashed by 1323.34% in 2025.
  • Over the past 5 years, Confluent's Capital Expenditures (Quarter) stood at $1.5 million in 2021, then surged by 88.03% to $2.8 million in 2022, then soared by 54.58% to $4.3 million in 2023, then grew by 26.08% to $5.4 million in 2024, then dropped by 0.2% to $5.4 million in 2025.
  • Its Capital Expenditures was $5.4 million in Q3 2025, compared to $6.2 million in Q2 2025 and $4.8 million in Q1 2025.